Sodertalje, Sweden

Ylva Gravenfors

USPTO Granted Patents = 3 


Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Sodertalje, SE (2012 - 2015)
  • Södertälje, SE (2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Ylva Gravenfors

Introduction: Ylva Gravenfors is a prominent inventor based in Södertälje, Sweden. With a strong commitment to advancing therapeutic technologies, she holds three patents that focus on innovative compounds, particularly in the field of pharmacology.

Latest Patents: Among her latest inventions, Ylva has developed bis-(sulfonylamino) derivatives designed for use in therapy. These compounds are characterized by specific structural formulas, exhibiting the potential to inhibit microsomal prostaglandin E synthase-1, a significant target for therapeutic intervention. Another noteworthy patent is her work on heteroaryl substituted benzothiazoles. This invention not only covers novel derivatives but also therapeutic applications that facilitate the imaging of amyloid deposits in living patients. This method is particularly crucial for the antemortem diagnosis of Alzheimer's disease and assessing the clinical efficacy of related therapeutic agents.

Career Highlights: Ylva Gravenfors has made significant contributions to the field through her work at reputable organizations such as AstraZeneca AB and Navidea Biopharmaceuticals, Inc. Her dedication and expertise in pharmaceutical development have made her a key player in advancing therapeutic solutions.

Collaborations: Throughout her career, Ylva has collaborated with notable colleagues, including Gunnar Nordvall and Daniel Sohn. These partnerships have fostered an environment of innovation and have been instrumental in driving her projects forward.

Conclusion: Ylva Gravenfors stands out as an influential inventor in the pharmaceutical industry. Her innovative patents reflect her dedication to enhancing therapeutic approaches, especially in the diagnosis and treatment of Alzheimer’s disease. As her work continues to evolve, she remains a vital contributor to the field of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…